EUVIMEDEUVIMED entdecken
Crossref

Concomitant lansoprazole ameliorates cisplatin‐induced nephrotoxicity by inhibiting renal organic cation transporter 2 in rats

Shun-Ichi Hiramatsu, Kenji Ikemura iD, Yutaka Fujisawa, Takuya Iwamoto, Masahiro Okuda

Biopharmaceutics & Drug Disposition · 2020-06 · 41 (6) · 239-247

DOI: 10.1002/bdd.2242 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biopharmaceutics & Drug Disposition, online erschienen am 25.06.2020. Verfasst von Shun-Ichi Hiramatsu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Biopharmaceutics, Mie University Graduate School of Medicine, Tsu, Mie, Japan. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cisplatin is used widely for the treatment of multiple solid tumors. Cisplatin‐induced nephrotoxicity is caused by renal accumulation of cisplatin via human organic cation transporter 2 (hOCT2). As lansoprazole, a proton pump inhibitor, is known to inhibit hOCT2 activity, lansoprazole might ameliorate cisplatin‐induced nephrotoxicity. A previous study showed that concomitant lansoprazole administration ameliorated nephrotoxicity in patients receiving cisplatin. However, the detailed mechanism remains to be clarified. In the present study, the drug–drug interaction between lansoprazole and cisplatin was examined using hOCT2‐expressing cultured cells and rat renal slices. Moreover, the effect of lansoprazole on cisplatin‐induced nephrotoxicity and the pharmacokinetics of cisplatin in rats was investigated. In the uptake study, lansoprazole potently inhibited the uptake of cisplatin in hOCT2‐expressing cultured cells and rat renal slices. The in vivo rat study showed that concomitant lansoprazole significantly ameliorated cisplatin‐induced nephrotoxicity and reduced the renal accumulation of platinum up to approximately 60% of cisplatin alone at 72 h after cisplatin intraperitoneal administration. Furthermore, the renal uptake of platinum at 3 min after intravenous cisplatin administration in rats with cisplatin and lansoprazole decreased to 78% of rats with cisplatin alone. In addition, there was no significant difference in the plasma platinum concentration between rats treated with and without lansoprazole at 3 min after cisplatin intravenous administration. These findings suggested that concomitant lansoprazole ameliorated cisplatin‐induced nephrotoxicity by inhibiting rOCT2‐mediated cisplatin uptake in rats, thus decreasing cisplatin accumulation in the kidney. The present findings provided important information for the establishment of novel protective approaches to minimize cisplatin‐induced nephrotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsAntineoplastic AgentsCisplatinHEK293 CellsHumansKidneyKidney DiseasesLansoprazoleMaleOrganic Cation Transporter 2Protective AgentsRats, Wistar

Stichwörter der Autor:innen

cisplatinlansoprazolenephrotoxicityorganic cation transporter 2

Substanzen

Antineoplastic AgentsOrganic Cation Transporter 2Protective AgentsLansoprazoleCisplatin

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Biopharmaceutics, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
  • Department of Pharmacy, Osaka University Hospital, Suita, Osaka, Japan.
  • Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Mie, Japan.
  • Department of Pharmacy, Mie University Hospital, Tsu, Mie, Japan.

ORCID-Profile: Kenji Ikemura

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Hiramatsu, S. I., Ikemura, K., Fujisawa, Y., Iwamoto, T., & Okuda, M. (2020). Concomitant lansoprazole ameliorates cisplatin‐induced nephrotoxicity by inhibiting renal organic cation transporter 2 in rats. Biopharmaceutics & Drug Disposition, 41(6), 239-247. https://doi.org/10.1002/bdd.2242

Vancouver

Hiramatsu SI, Ikemura K, Fujisawa Y, Iwamoto T, Okuda M. Concomitant lansoprazole ameliorates cisplatin‐induced nephrotoxicity by inhibiting renal organic cation transporter 2 in rats. Biopharmaceutics & Drug Disposition. 2020;41(6):239-247. doi:10.1002/bdd.2242

BibTeX
@article{Hiramatsu2020,
  author = {Hiramatsu, Shun-Ichi and Ikemura, Kenji and Fujisawa, Yutaka and Iwamoto, Takuya and Okuda, Masahiro},
  title = {Concomitant lansoprazole ameliorates cisplatin‐induced nephrotoxicity by inhibiting renal organic cation transporter 2 in rats},
  journal = {Biopharmaceutics & Drug Disposition},
  year = {2020},
  volume = {41},
  number = {6},
  pages = {239--247},
  doi = {10.1002/bdd.2242}
}
Kostenlos starten →